These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16100449)

  • 1. Comparison of clinical efficacy of Newfactan versus Surfacten for the treatment of respiratory distress syndrome in the newborn infants.
    Choi CW; Hwang JH; Yoo EJ; Kim KA; Koh SY; Lee YK; Shim JW; Lee EK; Chang W; Kim SS; Chang YS; Park WS; Shin SM
    J Korean Med Sci; 2005 Aug; 20(4):591-7. PubMed ID: 16100449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea.
    Shin JE; Yoon SJ; Lim J; Han J; Eun HS; Park MS; Park KI; Lee SM
    J Korean Med Sci; 2020 Aug; 35(32):e253. PubMed ID: 32808509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant treatment in the neonate with severe respiratory distress syndrome.
    Horpaopan S; Sangtaveesin V; Ratrisawasdi V
    J Med Assoc Thai; 1996 Apr; 79(4):222-8. PubMed ID: 8708507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
    Wright K
    J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study].
    Wauer RR; Schmalisch G; Rogalski M
    Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified surfactant dosing procedure in respiratory distress syndrome: the "side-hole" randomized study. Spanish Surfactant Collaborative Group.
    Valls-i-Soler A; López-Heredia J; Fernández-Ruanova MB; Gastiasoro E
    Acta Paediatr; 1997 Jul; 86(7):747-51. PubMed ID: 9240884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory distress syndrome treated with human surfactant: radiographic findings.
    Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
    Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS).
    Santin R; Brodsky N; Bhandari V
    J Perinatol; 2004 Aug; 24(8):487-93. PubMed ID: 15141265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.